Case studies

"It really is saving us a huge number of hours over the days, weeks and months. Having more relevant support at hand, not having to draft or review documents them from scratch - it all adds up."

Southampton FC

Access all 84 documents on Packaging

GET ACCESS NOW

GLOSSARY

Packaging definition

Published by a LexisNexis Energy expert

What does Packaging mean?

Fuel packaging: A special way of processing spent fuel for temporary storage or final disposal. Waste packaging: An operation whereby waste is converted into a form suitable for transportation and/or storage and/or final disposal. (a) Very low-level radioactive waste (vinyl, cleaning rags, etc.) is placed in steel drums. (b) Low- and intermediate-level waste is first compacted to reduce its volume as far as possible, then encapsulated in a special material (concrete, bitumen or resin matrix) to form solid blocks capable of withstanding all environmental conditions. (c) High-level waste is placed in a glass mixture (vitrification process). Once vitrified, the waste is placed in stainless steel canisters.

Speed up all aspects of your legal work with tools that help you to work faster and smarter. Win cases, close deals and grow your business–all whilst saving time and reducing risk.

Assignment of intellectual property rights (asset purchase)—checklist

Assignment of intellectual property rights (asset purchase)—checklist This Checklist is designed to highlight issues that commonly need to be addressed when drafting long-form and short-form assignments of intellectual property rights (IPRs) in an asset purchase scenario, and is to be used with the following Precedents: • Assignment of intellectual property rights (asset purchase) (long form) • Assignment of intellectual property rights (asset purchase) (short form) For licences of IPRs in an asset purchase scenario consider: • Precedent: Intellectual property licence (asset purchase) (long form) • Precedent: Intellectual property licence (asset purchase) (short form) • Intellectual property rights licence (asset purchase)—checklist For further information on issues raised by this Checklist, see the following Practice Notes: • Assigning intellectual property rights • Licensing intellectual property rights • Sub-licensing intellectual property rights • Key issues in software licence agreements • Know-how—protection and licensing • Tax issues and incentives arising from assignment and licensing of IP Key terms for inclusion in an assignment of intellectual property rights (IPRs) in an asset purchase...

Key IP considerations in R&D agreements—checklist

Key IP considerations in R&D agreements—checklist Using this Checklist This Checklist focuses on the IP aspects of R&D agreements and identifies the key terms typically included in an R&D agreement. This document can be used as a checklist of issues to consider when drafting, reviewing or negotiating such agreements. Key competition law considerations are also considered. However, an individual assessment will need to be conducted as to whether an agreement’s IP provisions are compatible with competition law, particularly the prohibitions against anti-competitive agreements under Article 101(1) of the Treaty on the Functioning of the European Union (TFEU) and Chapter I of the Competition Act 1998 (CA 1998). On 1 June 2023, the European Commission adopted the EU Research & Developments Block Exemption, Commission Regulation (EU) 2023/1066 (EU R&D BER) and the accompanying Horizontal Guidelines. The EU R&D BER entered into force on 1 July 2023 and will expire on 30 June 2035. On 5 December 2022, the UK government laid before Parliament the Competition Act 1998 (Research and Development...

Discover our 6 Checklists on Packaging

What is considered advertising of medicinal products?

What is considered advertising of medicinal products? This Practice Note examines the meaning of advertising within the regulatory framework on the advertising and promotion of medicinal products. It considers what activities may constitute advertising and therefore fall within the scope of the strict rules on advertising and promotion of medicinal products. Note that this Practice Note contains references to case law of the Court of Justice of the European Union. For guidance on whether judgments of the Court of Justice are binding on UK courts, see Practice Note: Assimilated law—Assimilated case law . Advertising within the regulatory framework in the UK and EU Not all information referring to a particular medicinal product is considered promotional or constitutes advertising, but it is a fine line that can be difficult to discern with potentially serious repercussions for pharmaceutical companies and other parties involved with the communication of information about medicines. For more information about the potential sanctions and enforcement procedure in the UK, see Practice Note: Enforcement of the rules...

Sentencing individuals convicted of gross negligence manslaughter

Sentencing individuals convicted of gross negligence manslaughter Gross negligence manslaughter is a common law offence and occurs when the offender: • is in breach of a duty of care towards the victim • the breach causes the death of the victim, and • having regard to the risk involved, the offender’s conduct was so bad as to amount to a criminal act or omission For information on the offence of manslaughter by gross negligence, see Practice Note: Involuntary manslaughter. Gross negligence manslaughter can only be committed by an individual and should not be confused with manslaughter caused by a corporation which is a statutory offence created by the Corporate Manslaughter and Corporate Homicide Act 2007. For information on the offence of corporate manslaughter, see: Corporate manslaughter—overview and Practice Note: Corporate manslaughter—an introductory guide. The sentencing of organisations for corporate manslaughter is addressed in the Crown Court offence-specific guidelines for corporate manslaughter. See Practice Note: Sentencing for corporate manslaughter. The Sentencing Council has published an offence-specific guideline...

Discover our 42 Practice Notes on Packaging

Licence to use photographs

Licence to use photographs This Agreement is made on [insert date] (the Commencement Date) between the following parties (each a party and together the parties): Parties 1 [insert licensor name] a company incorporated in [England and Wales] whose registered number is [insert company number] and whose registered office is at [insert registered office] (the ‘Licensor’); and 2 [insert licensee name] a company incorporated in [England and Wales] whose registered number is [insert company number] and whose registered office is at [insert registered office] (the ‘Licensee’). Background (A) Licensor is the proprietor of the Photographic Works. (B) Licensor wishes to license the Photographic Works to Licensee and Licensee wishes to receive the same on the terms of this Agreement. The parties agree: 1 Definitions and interpretation 1.1 Definitions In this Agreement: Affiliate • means any entity that directly or indirectly controls, is controlled by or is under common control with, another entity; Control • means that a person owns directly or indirectly more than 50% of...

Minimum purchase clause

Minimum purchase clause Definitions Minimum Purchase Commitment • means the commitment to [purchase the Minimum Quantities OR place Orders with an aggregate minimum Price] as set out at clause 1.1; [Minimum Quantities • has the meaning given to it in [insert schedule];] [Order • means a written order for Products in the form prescribed by this Agreement[ or in any other form that the parties may agree from time to time in writing];] [Price • means the price payable by the Customer in respect of any Order for Products exclusive of: packaging, freight and insurance costs; customs and export or import duties; and VAT (or equivalent sales tax), withholding or other tax;] 1 Minimum purchase clause 1.1 [Subject to adjustment in accordance with the provisions of clause 1.3, in OR In] each Contract Year during the Term, the Customer agrees to [purchase the Minimum Quantities OR submit Orders with an aggregate Price of not less than [insert amount] in respect] of the Products.

Dive into our 28 Precedents related to Packaging

New Clinical Trials Regulations will bring UK closer to EU regime

Life Sciences analysis: Rory Trust, director and Fraser Campbell, trainee solicitor at Burges Salmon LLP, consider the new UK Clinical Trials Regulations which are coming into force in 2026. They also make a comparison between the UK and EU clinical trial regime, among other things.

Environment Agency announces £477,000 conviction for waste packaging data fraud

The Environment Agency has announced the conviction of Shaobo Qin, director of EDU Case Ltd, for making fraudulent entries on the National Packaging Waste Database (NPWD). On 16 May 2025, Birmingham Crown Court ordered payments totaling £476,995, which included a £255,057 confiscation order issued under the Proceeds of Crime Act 2002 (PoCA 2002), a £200,000 company fine, and £21,995 in investigation costs. Qin pleaded guilty to fraud by false representation and received a two-year prison sentence for entering false data regarding 785.4 tonnes of non-existent plastic waste exports in 2022. This fraud accounted for approximately two-thirds of the company's trading volume. The case was prosecuted under the Fraud Act 2006 (FrA 2006), while the company operated under the Producer Responsibility Obligations (Packaging Waste) Regulations 2007 (PRO(PW)R 2007), SI 2007/871.

Read the latest 14 News articles on Packaging